Join
Live feed
·
PRReleasevia Quantisnow
Citius Pharmaceuticals Inc. logo

Citius Pharmaceuticals to Host Investor Call to Discuss Topline Results of Phase 3 Trial of Mino-Lok Antibiotic Lock Solution

ByQuantisnow·Wall Street's wire, on your screen.
CTXR· Citius Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTXR (Citius Pharmaceuticals Inc.) and more on Quantisnow.